Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity
- 1 August 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 17 (4) , 462-465
- https://doi.org/10.1249/00005768-198508000-00010
Abstract
Serum lipids and postheparin plasma lipolytic activities were studied in 5 weightlifters presently self-administering androgenic steroids (users) and an equal number not currently using these drugs (non-users). Mean (.+-. SD) age (23 .+-. 2 vs. 25 .+-. 4 yr), body wt (102.7 .+-. 11.4 vs. 86.8 .+-. 13.6 kg), and percent body fat (8.6 .+-. 2.5 vs. 7.8 .+-. 6.0%) were not different in users and non-users, respectively. Similarly, there were no differences in total cholesterol (183 .+-. 27 vs. 176 .+-. 32 mg .cntdot. dl-1) low-density lipoprotein-cholesterol (138 .+-. 25 vs. 108 .+-. 32 mg .cntdot. dl-1), or triglyceride (93 .+-. 26 vs. 93 .+-. 41 mg .cntdot. dl-1) levels in the 2 groups. High-density lipoprotein (HDL)-cholesterol concentrations were significantly lower in the users (26 .+-. 10 vs. 50 .+-. 13 mg .cntdot. dl-1; P < 0.05), and most of the difference was due to lower HDL2-cholesterol concentrations (6 .+-. 4 vs. 22 .+-. 9 mg .cntdot. dl-1; P < 0.05). Postheparin plasma lipoprotein lipase activity was only slightly lower in the users (3.49 .+-. 2.23 vs. 5.36 .+-. 1.73 .mu.mol FFA [free fatty acid] .cntdot. ml-h-1; P = NS [not significant]), but hepatic triglyceride lipase activity was significantly higher in this group (27.99 .+-. 6.89 vs. 11.15 .+-. 2.76, .mu.mol FFA .cntdot. ml-hr-1; P < 0.001) and correlated inversely with HDL2-cholesterol concentrations (r = -0.81; P < 0.01). Androgenic hormones reduce HDL-cholesterol concentrations and the HDL2-cholesterol subfraction, possibly by enhancing hepatic triglyceride lipase activity.This publication has 16 references indexed in Scilit:
- High Density Lipoprotein-2 and Hepatic Lipase: Reciprocal Changes Produced by Estrogen and Norgestrel*Journal of Clinical Endocrinology & Metabolism, 1982
- Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosisPublished by Elsevier ,1982
- Reduction of plasma high-density lipoprotein2 cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatmentClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man—evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in manAtherosclerosis, 1980
- High density lipoproteins during hypolipidemic therapyAtherosclerosis, 1980
- Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.Circulation, 1980
- EFFECT OF ACUTE VIGOROUS EXERCISE ON LIPOPROTEIN-LIPASE ACTIVITY OF ADIPOSE-TISSUE AND SKELETAL-MUSCLE IN PHYSICALLY ACTIVE MEN1980
- Generalized equations for predicting body density of menBritish Journal of Nutrition, 1978
- Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: Relation to serum lipoproteinsMetabolism, 1978